Nuclera
Founded 2013 · 3 known investors
Nuclera develops eProtein Discovery, a benchtop protein screening system that uses cell-free protein synthesis and digital microfluidics to design, screen, characterize, and express proteins in-house. It serves research scientists working on antibody discovery and protein studies, including soluble, membrane, and antibody fragment targets.
BiotechDeep TechHardware
Investors · 3
Frequently asked questions
- What does Nuclera do?
- Nuclera develops eProtein Discovery, a benchtop protein screening system that uses cell-free protein synthesis and digital microfluidics to design, screen, characterize, and express proteins in-house. It serves research scientists working on antibody discovery and protein studies, including soluble, membrane, and antibody fragment targets.
- Who are Nuclera's investors?
- Nuclera's investors include Amadeus Capital Partners, Future Planet Capital, Cambridge Innovation Capital.